Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Clinical trial NCT07051629 · RECRUITING
Trial details
- NCT number
- NCT07051629
- Sponsor
- Suninflam Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-16
- Primary completion
- 2027-01-15
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.